We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Express Scripts Backs Inexpensive Challenger to Turing’s Daraprim
Express Scripts Backs Inexpensive Challenger to Turing’s Daraprim
The nation’s largest pharmacy benefits manager is throwing its support behind a cheaper alternative to Turing Pharmaceuticals’ expensive toxoplasmosis/HIV treatment, threatening its monopoly on the market.